Cheilitis

disease
On this page

Also known as inflammation of liplip inflammation

Summary

Cheilitis (MONDO:0002102) is a disease and 1 clinical trial. A subtype of lip disorder — broader associated-gene and molecular evidence is on the parent page (see Disease family below).

At a glance

  • Clinical trials: 1

Clinical features

No curated clinical features (Orphanet) for this disease.

Identifiers

Disease identifiers

FieldValue
Canonical namecheilitis
Mondo IDMONDO:0002102
MeSHD002613
DOIDDOID:1762
ICD-11482914030
NCITC79545
SNOMED CT7847004
UMLSC0007971
MedGen3349
Is cancer (heuristic)no

Also known as: inflammation of lip · lip inflammation

Data availability: 1 HPO phenotype.

Disease family

An umbrella term covering 3 Mondo subtypes.

Classification path: disease › human disease › disease by body system or component › mouth disorder › lip disorder › cheilitis

Related subtypes (3): lower lip fistula, lip neoplasm, herpes labialis

Subtypes (3): angular cheilitis, Melkersson-Rosenthal syndrome, actinic cheilitis

Genetics & variants

GWAS landscape

No GWAS associations recorded — common-variant (GWAS) studies don’t cover this disease (typical for Mendelian / rare diseases). See the curated gene cohort and Mendelian overlap below.

Variant details and genetic-evidence tiers

No tiered GWAS variants or ClinVar records for this disease.

Genes & proteins

No associated-gene cohort resolved for this disease. Atlas builds the molecular and therapeutic sections — associated genes, protein families, druggability, pathways, interactions, and drug associations — by aggregating over a disease’s associated genes (resolved via GWAS / GenCC / ClinVar / CIViC), and none resolved here. This is expected for antibody-mediated, autoimmune, or otherwise non-gene-defined conditions; the curated evidence for this disease is its clinical features, GWAS susceptibility, and clinical trials (above).

Function

No pathway enrichment — requires an associated-gene cohort.

Therapeutics

No druggable-target or therapeutic data for this disease’s cohort.

Clinical trials & evidence

Clinical trials

Clinical trials: 1.

Phase distribution (across all retrieved trials)

PhaseTrials
Not specified1

Top trials by phase / activity

NCTPhaseStatusTitle
NCT06475482Not specifiedCOMPLETEDDevelopment of a Novel Polyherbal Lip Hydrant for Improving Biophysical Barrier of the Lips

No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.